Business profile

Coryfea Biosciences Oy

Coryfea Biosciences Oy's registered office is Helsingfors. It is a limited company. The company was established on 2023-06-13. It operates in the industry of research and experimental development on natural sciences and engineering. In its latest retained statement for 2024-12-31, revenue was €162,977 and operating profit was €78,122.

Claim profileContact details
Business ID 3367189-8ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3367189-8
Sector
Research and experimental development on natural sciences and engineering
Municipality
Helsingfors
Company form
Limited company
Registration date
2023-06-13
Business ID registration date
2023-05-24
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Topeliuksenkatu 27 A 8, 00250, Helsingfors

About Coryfea Biosciences Oy

Financial position and key figures for the company.

Coryfea Biosciences Oy's location municipality is Helsingfors. It is a limited company. The company was established on 2023-06-13. It operates in the industry of research and experimental development on natural sciences and engineering. In its latest retained statement for 2024-12-31, revenue was €162,977 and operating profit was €78,122. The latest retained financial statement for 2024-12-31 shows revenue of €162,977 and profit for the financial year of €78,054. Based on the latest retained statement, revenue growth was +115.4%, operating margin was +47.9%, and equity ratio was +99.7%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2024-12-31

Imported periods2
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth115.4%
Operating margin47.9%
Equity ratio99.7%
Revenue€162,977+€87,307 (+115.4%) vs previous periodPrevious: €75,671
Operating profit (loss)€78,122+€77,969 (+51057.1%) vs previous periodPrevious: €153
Profit (loss) for the financial year€78,054+€77,902 (+50979.4%) vs previous periodPrevious: €153
Assets€78,443+€66,442 (+553.6%) vs previous periodPrevious: €12,002
Balance-sheet contextLatest financial period
Cash and bank€77,888Previous: €10,543
Retained earnings€153Previous: €0
Equity€78,207Previous: €153
Liabilities€236Previous: €11,849
Current assets€78,443Previous: €12,002
Current liabilities€236Previous: €11,849
Revenue trend2 periods
€75,671
2023-12-31
€162,977
2024-12-31
Operating profit (loss) trend2 periods
€153
2023-12-31
€78,122
2024-12-31
Profit (loss) for the financial year trend2 periods
€153
2023-12-31
€78,054
2024-12-31
Assets trend2 periods
€12,002
2023-12-31
€78,443
2024-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Improving
99.7 %2023-12-31: 1.3 %
Current ratioGood
100/100 · Improving
329.88x2023-12-31: 0.89x
Operating profit marginGood
100/100 · Improving
47.9 %2023-12-31: 0.2 %
Ratio history
Ratio2023-12-312024-12-31
Equity ratio1.3 %99.7 %
Current ratio0.89x329.88x
Operating profit margin0.2 %47.9 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3367189-8
VAT IDFI33671898
EU IDFIFPRO.3367189-8
MunicipalityHelsingfors
Current registered entries
2023-06-13Registered in Tax Administration (Tax Administration)
2023-06-13Registered in Patent and Registration Office (Trade Register)
2023-11-02VAT-liable for business activity in Tax Administration (VAT Register)
2023-11-02Registered in Tax Administration (Prepayment Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A2
Very goodCoryfea Biosciences Oy
Grade unchangedA2 · new analysis 2026-10-17
Model score80/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectorySeveral key financial indicators show coordinated recovery.
2 comparable periods
RevenueImproving
ProfitabilityImproving
SolvencyImproving
LiquidityImproving
Peer comparisonSame size nationallyDescriptive comparison – does not change the model score.
3278 peers
Solvency99%
Better than 99% of peers
Profitability93%
Better than 93% of peers
Liquidity100%
Better than 100% of peers
Revenue growth94%
Better than 94% of peers
Financial statement reporting patternMixedBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
2 observed filings
Latest registration lag127 days after period end
Typical registration lag209 days after period end
Annual continuity2 consecutive periods
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Healthy short-term liquidity
Risk factors to note
  • Elevated industry distress context
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
A2
2026-10-1780/100 · v0.15
A2 → A2
A2
2026-09-25 14:0780/100 · v0.14
B3 → A2 · +32 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2024-12-31).
  • Assessment confidence: Medium → High.
  • Evidence quality: Registry and statistical evidence → Strong financial evidence.
B3
2026-09-1548/100 · v0.14
B2 → B3 · -4 points
  • Assessment confidence: Low → Medium.
  • Evidence quality: Registry and statistical evidence → Registry and statistical evidence.
  • New risk factor: Sufficient structured financial metrics are not available.
B2
2026-09-1452/100 · v0.12
Oldest retained automatic assessment in this comparison
Automatic model gradeA2
Automatic model snapshot2026-10-17
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskelevated
48/100

Industry context is elevated based on normalized open statistical inputs.

Age and continuityNuori
35/100

The company has about 3 years of registry continuity.

Registry and status signalsRajallinen
41/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
25 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B3 → A2.
Risk grade updatedRisk gradeEvidence verified
15 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B3.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.

Registry timeline

Trade register notifications shown on a timeline.

6 register eventsLatest event: 2025-05-07

Financial statements availability

Available financial statement periods and PRH source filings.

2 financial statement periodsLatest financial period: 2024-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Coryfea Biosciences Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.